Szemészet, 2022 (159. évfolyam, 1-4. szám)
2022-03-01 / 1. szám
Case of bilateral panuveitis in a 59-year-old immunocompromised female patient I. Humoral immunity. Clin Exp Immunol 1974; 18:109-118. 10. Reeves M, Sinclair J. Aspects of human cytomegalovirus latency and reactivation. Cure. Top Microbiol Immunol 2008; 325: 297-313. https://doi.org/1O.1OO7/978-3-54O-77349-8_17 11. Zuhair M, Smit GSA, Wallis G, Jabbar F, Smith C, Devleesschauwer B, Griffiths P. Estimation of the worldwide seroprevalence of cytomegalovirus: A systematic review and meta-analysis. Rev Med Virol 2019; 29: e2034. https://doi.org/10.1002/rmv.2034 12. Varga M, Görög D, Kéri 0, Környei E, KisÉ, Túryné HJ, Jankovics I, Péter A, Toronyi É, Sárváry E, Fazakas J, Reusz G. Cytomegalovirus seroprevalence among solid organ donors in Hungary: correlations with age, gender, and blood group. Transplant Proc 2011 May; 43(4): 1233-5. https://doi.Org/10.1016/j.transproceed.2011.03.067 13. Bosamiya SS. The immune reconstitution inflammatory syndrome. Indian J Dermatol 2011; 56: 476-479. https://doi.org/10.4103/0019-5154.87114 14. Gulick RM, Mellors JW, Havlir D, Erőn, JJ, Gonzalez C, McMahon D, Richman DD, Valentine FT, Jonas L, Meibohm A, et al. Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy. N Engl J Med 1997; 337: 734-739. https://doi.org/10.1056/NEJM199709113371102 15. Carmichael A. Cytomegalovirus and the eye. Eye (Lond.) 2012; 26: 237-240. 16. Patra S, Samal SC, Chacko A, Vadakenadayil I, MMM M. Cytomegalovirus infection of the human gastrointestinal tract. Journal of Gastroenterology and Hepatology 1999; 14(10): 973-976. 2. táblázat: CMV-fertőzésben alkalmazott antivirális szerek. Forrás: American Academy of Ophthalmology . aspx?id=8f182331-5b2e-4199-a851-a682b283222c https://www.aao.org/focalpointssnippetdetail https://doi.org/10.1038/eye.2011.327 17. Jabs DA, Ahuja, A, Van Natta, ML, Lyon, AT, Yeh, S, Danis R. Long-term Outcomes of Cytomegalovirus Retinitis in the Era of Modern Antiretroviral Therapy: Results from a United States Cohort. Ophthalmology 2015; 122: 1452-1463. https://doi.Org/10.1016/j.ophtha.2015.02.033 18. Spaide RF, Gaissinger A, Podhorzer JR. Risk factors for cotton-wool spots and for cytomegalovirus retinitis in patients with human immunodeficiency virus infection. Ophthalmology 1995; 102:1860-1864. https://doi.org/10.1016/s0161-6420(95)30783-x 19. Cadogan M, Dalgleish AG. HIV immunopathogenesis and strategies for intervention. Lancet Infect Dis 2008; 8: 675-684. https://doi.org/10.1016/S1473-3099(08)70205-6 20. Piukovics K, Terhes G, Bereczki Á, Borbényi Z, Gurbity Pálfi T, Kővári B, Urbán E. Monitoring cytomegalovirus infection and reactivation using quantitative real-time polymerase chain reaction in patients with haematological malignancies during chemotherapy and after autologous stem cell transplantation. Orv Hetil 2016 Aug; 157(35): 1403-9. https://doi.org/10.1556/650.2016.30516 21. Miao H, Tao Y, Jiang YR, Li XX. Multiple intravitreal injections of ganciclovir for cytomegalovirus retinitis after stem-cell transplantation. Graefes Arch Clin Exp Ophthalmol Graefes Arch Clin Exp Ophthalmol 2013 Jul; 251(7): 1829v33. https://doi.org/10.1007/s00417-013-2368-6 22. Derzko-Dzulynsky LA, Berger AR, Berinstein NL. Cytomegalovirus retinitis and low-grade non-Hodgkin’s lymphoma: Case report and review of the literature. Am J Hematol 1998; 57: 228-232. https://doi.org/10.1002/(sici)1096-8652(199803)57:3<228::aid-ajh9>3.0.co;2-x 23. Hodge WG, Boivin JF, Shapiro SH, Lalonde RG, Shah KC, Murphy BD, Diaz-Mitoma F. Laboratory-based risk factors for cytomegalovirus retinitis. Can J Ophthalmol 2004; 39: 733-745. https://doi.org/10.1016/s0008-4182(04)80067-x 24. Delyfer MN, Rougier MB, Hubschman JP, Aouizerate F, Korobelnik JF. Cytomegalovirus retinitis following intravitreal injection of triamcinolone: Report of two cases. Acta Ophthalmol Scand 2007; 85: 681-683. https://doi.Org/10.1111/j.1600-0420.2007.00915.x 25. Kulshrestha MK, Goble RR, Murray PI. Cytomegalovirus retinitis associated with long term oral corticosteroid use. Br J Ophthalmol 1996; 80: 849-850. https://doi.Org/10.1136/bjo.80.9.849-a 26. Lai TY, Wong RL, Luk FO, Chow VW, Chan CK, Lam DS. Ophthalmic manifestations and risk factors for mortality of HIV patients in the post-highly active anti-retroviral therapy era. Clin Exp Ophthalmol 2011; 39: 99-104. https://doi.Org/10.1111/j.1442-9071.2010.02400.x 27. Kuppermann BD, Petty JG, Richman DD, Mathews WC, Fullerton SC, Rickman LS, Freeman WR. Correlation between CD4+ counts and prevalence of cytomegalovirus retinitis and human immunodeficiency virus-related noninfectious retinal vasculopathy in patients with acquired immunodeficiency syndrome. Am J Ophthalmol 1993; 115: 575-582. https://doi.org/1O.1O16/sOOO2-9394(14)71453-9 28. Wei LL, Park SS, Skiest DJ. Prevalence of visual symptoms among patients with newly diagnosed cytomegalovirus retinitis. Retina 2002; 22: 278-282. https://doi.org/10.1097/00006982-200206000-00004 29. Wren SM, Fielder AR, Bethell 0, Lyall EG, Tudor-Williams G, Cocker KD, Mitchell SM. Cytomegalovirus Retinitis in infancy. Eye (Lond.) 2004; 18: 389-392. https://doi.org/10.1038/sj.eye.6700696 30. Rabb MF, Jampol LM, Fish RH, Campo RV, Sobol WM, Becker NM. Retinal periphlebitis in patients with acquired immunodeficiency syndrome with cytomegalovirus retinitis mimics acute frosted retinal periphlebitis. Arch Ophthalmol 1992 Sep; 110(9): 1257-60. https://doi.org/10.1001/archopht.1992.01080210075028 31. Geng S, Ye JJ, Zhao JL, Li TS, Han Y. Cytomegalovirus retinitis associated with acquired immunodeficiency syndrome. Chin Med J (Engl.) 2011; 124: 1134-1138. 32. Walter KA, Coulter VL, Palay DA, Taravella MJ, Grossniklaus HE, Edel häuser HF. Corneal endothelial deposits in patients with cytomegalovirus retinitis. Am J Ophthalmol 1996; 121: 391-396. https://doi.org/10.1016/s0002-9394(14)70435-0 33. Gupta MP, Patel S, Orlin A, Marlow E, Chee RI, Nadelmann J, Chan RVP, D'Amico DJ, Kiss S. Spectral domain optical coherence tomography findings in macula-involving cytomegalovirus retinitis. Retina 2018 May; 38(5): 1000-1010. https://doi.org/10.1097/IAE.0000000000001644 34. Maguire AM, Nichols CW, Crooks GW. Visual loss in cytomegalovirus retinitis caused by cystoid macular edema in patients without the acquired immune deficiency syndrome. Ophthalmology 1996 Apr; 103(4): 601-5. https://doi.org/10.1016/s0161-6420(96)30646-5 35. Standardization of Uveitis Nomenclature (SUN) Working Group. Classification Criteria for Cytomegalovirus Retinitis. Am J Ophthalmol 2021 Aug; 228: 245-254. https://doi.Org/1O.1O16/j.ajo.2O21.O3.O51 36. Drenaggi D, Pauri P, Sigismondi C, Nuzzo MM, Mariwan I, Schimizzi AM, Cerioni 0, Brugia M, Scalise G. Observations about the treatment of Cytomegalovirus retinitis in patients with HIV infection using Ganciclovir and Foscarnet. InfezMed 1998; 6:148-152. 37. Vadlapudi AD, Vadlapatla RK, Mitra AK. Current and emerging antivirals for the treatment of cytomegalovirus (CMV) retinitis: An update on recent patents. Recent Pat Anti-lnfect Drug Discov 2012; 7: 8-18. https://doi.org/1O.2174/157489112799829765 38. Martin DF, Sierra-Madero J, Walmsley S, Wolitz RA, Macey K, Georgiou P, Robinson CA, Stempien MJ. A controlled trial of valganciclovir as induction therapy for cytomegalovirus retinitis. N Engl J Med 2002; 346: 1119-1126. https://doi.org/10.1056/NEJMoa011759 39. Lurain NS, Chou S. Antiviral drug resistance of human cytomegalovirus. Clin Microbiol Rev 2010; 23: 689-712. https://doi.org/10.1128/CMR.00009-10 40. Roehr B. Fomivirsen approved for CMV retinitis. J Int Assoc Physicians AIDS Care 1998 Oct; 4(10): 14-6. 41. Iu LP, Fan MC, Lau JK, Chan TS, Kwong YL, Wong IY. Long-term Follow-up of Cytomegalovirus Retinitis in Non-HIV Immunocompromised Patients: Clinical Features and Visual Prognosis. Am J Ophthalmol 2016; 165: 145-153. https://doi.Org/10.1016/j.ajo.2016.03.015 42. Kim DY, Jo J, Joe SG, Kim JG, Yoon YH, Lee JY. Comparison of Visual Prognosis and Clinical Features of Cytomegalovirus Retinitis in Hiv and Non-Hiv Patients. Retina 2017; 37: 376-381. https://doi.org/10.1097/IAE.0000000000001144 Dr Gyenes Andrea, 1085 Budapest, Mária u. 39. E-mail: drgyenesandrea@gmail.com { 23 ■